With manufacturing sites across the US, UK, Germany and Denmark, LGC Biosearch Technologies has plans to continue growing. We deliver mission critical genomics to our diverse customer base in molecular diagnostics, pharma/biotech and agrigenomics. Our integrated portfolio of products, services and expertise supports our purpose of Science for a Safer World and we have embodied our mission by working with customers to enable research into life-altering treatment for disease and illness worldwide. We are currently seeking candidates who are up for the challenge of operating in a high-growth, purpose-driven organisation.
We encourage team collaboration and in doing so, we have created our own way of reaching objectives and taking care of our people. Here at LGC, we are deeply rooted in the behaviours we expect from all our colleagues, we will provide you with excellent opportunities, the latest technology and practices and we are passionate about making a difference.
LGC’s Diagnostic and Genomics site develops and manufactures a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials for the extended life sciences industry. We partner with IVD assay developers, and pharmaceutical, CRO and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early stage research, through expedited product development and onwards into routine clinical use. Laboratorians and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics and clinical genomics rely on LGC’s products to support accurate and reliable diagnostic results.
Our operating entities include The Native Antigen Company, which is a manufacturer and supplier of antigens and antibodies, which are key components in vaccine research, and for the accurate diagnosis of a wide range of infectious diseases. Our customer base includes key Pharmaceutical and IVD companies, in addition to the academic sector and a wide range of Biotechnology companies. Alongside The Native Antigen Company, the Clinical Diagnostics Business Unit also includes SeraCare Life Sciences, Maine Standards Company and Technopath, which are in vitro diagnostics (IVD) manufacturers of quality measurement tools (calibrators, controls, linearity, EQA/PT, biological materials). Our 450+ employees operate an ISO 9001-accredited facility in Oxford, UK, and FDA-registered and ISO 13485-accredited facilities in Maine, Massachusetts and Maryland, USA, and Tipperary, Ireland.
Each day, our world-class staff, scientific expertise, operational efficiency and superior quality systems are ready to support the range of advanced technologies that collectively improve patient outcomes - from the widely adopted and established through to cutting-edge NGS and precision diagnostics.